A live map of the Biotech sector: 466 companies tracked, $16.2B raised across 550 funding rounds. Below: the most-funded companies, the investors most active in Biotech, and the latest rounds.
| Company | Rounds | Raised |
|---|---|---|
| Isomorphic Labs | 1 round | $2.1B |
| Xaira Therapeutics | 1 round | $1B |
| Coefficient Bio | 1 round | $400M |
| Tubulis | 1 round | $357M |
| Normax Biomed | 1 round | $300M |
| Calypso Biotech | 2 rounds | $278M |
| Cellares | 1 round | $277M |
| Colossal Biosciences | 2 rounds | $270M |
| Altos Labs | 1 round | $270M |
| Noema Pharma | 2 rounds | $250.5M |
| Chai Discovery | 2 rounds | $200M |
| Asimov | 1 round | $200M |
| Genesis Therapeutics | 1 round | $200M |
| Leyden Labs | 3 rounds | $199M |
| Adcendo | 3 rounds | $185.8M |
| DNA Script | 1 round | $176.8M |
| Vaccitech | 1 round | $168M |
| Complement Therapeutics | 2 rounds | $149M |
| VectorY Therapeutics | 1 round | $138M |
| Hemab Therapeutics | 1 round | $135M |
| MinervaX | 3 rounds | $134.3M |
| ATAI Life Sciences | 1 round | $125M |
| GH Research | 1 round | $125M |
| Nimbus Therapeutics | 1 round | $125M |
| Jun 2026 | Gate2Brain — unknown | $7.6M |
| Jun 2026 | Dioseve — series a | $6.5M |
| Jun 2026 | Biodimension — unknown | $920K |
| Jun 2026 | Cellares — series d plus | $277M |
| Jun 2026 | Tomorrowlabs — round | — |
| Jun 2026 | Immuneel Therapeutics — series b | $10.5M |
| Jun 2026 | Haga Bioscience — seed | $2.3M |
| Jun 2026 | IMU Biosciences — series a | $53M |
| Jun 2026 | Mantis Biotech — seed | $7M |
| Jun 2026 | 10x Science — seed | $4.8M |